相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risperidone long-acting injection: a review of its long term safety and efficacy
Michael Rainer
Neuropsychiatric Disease and Treatment (2011)
Long-acting risperidone: a review of its role in the treatment of bipolar disorder
David E. Kemp et al.
ADVANCES IN THERAPY (2009)
Enhancing outcomes in patients with bipolar disorder: results from the Bipolar Disorder Center for Pennsylvanians Study
Andrea Fagiolini et al.
BIPOLAR DISORDERS (2009)
A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently
Wayne Macfadden et al.
BIPOLAR DISORDERS (2009)
Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness
Samuel Keith
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Improving adherence in mood disorders: the struggle against relapse, recurrence and suicide risk
Maurizio Pompili et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Use of Risperidone Long-Acting Injection to Support Treatment Adherence and Mood Stabilization in Pediatric Bipolar Patients: A Case Series
Lee Fu-I et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Akathisia: An Updated Review Focusing on Second-Generation Antipsychotics
John M. Kane et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Maintenance Electroconvulsive Therapy Combined With Long-Acting Risperidone in the Treatment of Resistant Bipolar Affective Disorder
Cem Sengul et al.
JOURNAL OF ECT (2009)
Antipsychotic-induced extrapyramidal symptoms and their management
Praveen Dayalu et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients
Rao N. Malempati et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2008)
Risperidone long-acting injectable for maintenance therapy in bipolar disorder: An open-label pilot study
Peter Braeunig et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2008)
Elderly patients with dementia-related symptoms of severe agitation and aggression: Consensus statement on treatment options, clinical trials methodology, and policy
Carl Salzman et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Anti psychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia - A systematic review
Keming Gao et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Long-Acting Risperidone-Induced Periorbital Edema
Lorenzo Pelizza
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia
Veronica O'Keane
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone
Eduard Vieta et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2008)
Absorption, metabolism, and excretion of paliperidone, a new monoaminergic antagonist, in humans
Marc Vermeir et al.
DRUG METABOLISM AND DISPOSITION (2008)
Adjunctive treatment with a dopamine partial agonist, aripiprazole, for anti psychotic-induced hyperprolactinemia: A placebo-controlled trial
Joo-Cheol Shim et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Branch retinal artery occlusion after injection of a long-acting risperidone preparation
Johnny Tang et al.
ANNALS OF INTERNAL MEDICINE (2007)
Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder
Changsu Han et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Second-generation antipsychotic agents in the treatment of acute mania - A systematic review and meta-analysis of randomized controlled trials
Harald Scherk et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Extrapyramidal adverse events associated with atypical antipsychotic treatment of bipolar disorder
Salvatore Gentile
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Depot antipsychotic medications in bipolar disorder: a review of the literature
D. J. Bond et al.
ACTA PSYCHIATRICA SCANDINAVICA (2007)
A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder
L. N. Yatham et al.
ACTA PSYCHIATRICA SCANDINAVICA (2007)
Nontricyclic antidepressants - Predictors of nonadherence
Oscar H. Brook et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Use of long-acting risperidone in the treatment of bipolar patients
Haluk A. Savas et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment
Ana Gonzalez-Pinto et al.
BIPOLAR DISORDERS (2006)
Serum concentrations of risperidone and 9-OH risperidone following intramuscular injection of long-acting risperidone compared with oral risperidone medication
R Nesvåg et al.
ACTA PSYCHIATRICA SCANDINAVICA (2006)
Long-acting risperidone:: Focus on safety
Hans-Juergen Mueller
CLINICAL THERAPEUTICS (2006)
A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone
G Remington et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Predictors of recurrence in bipolar disorder: Primary outcomes from the systematic treatment enhancement program for bipolar disorder (STEP-BD)
RH Perlis et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Treatment-resistant bipolar depression: A STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone
AA Nierenberg et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Self-reported medication treatment adherence among veterans with bipolar disorder
M Sajatovic et al.
PSYCHIATRIC SERVICES (2006)
An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: Results from a long-term study
GM Gharabawi et al.
SCHIZOPHRENIA RESEARCH (2005)
Clinical improvement in 336 stable chronically psychotic patients changed from oral to long-acting risperidone: a 12-month open trial
RA Lasser et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
Long-acting risperidone in stable patients with schizoaffective disorder
A Mohl et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2005)
Minimal injection site pain and high patient satisfaction during treatment with long-acting risperidone
JP Lindenmayer et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2005)
Identifying and improving non-adherence in bipolar disorders
F Colom et al.
BIPOLAR DISORDERS (2005)
Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol
AB Smulevich et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2005)
Enhancement of treatment adherence among patients with bipolar disorder
M Sajatovic et al.
PSYCHIATRIC SERVICES (2004)
Consensus development conference on antipsychotic drugs and obesity and diabetes
DIABETES CARE (2004)
Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia
M Eerdekens et al.
SCHIZOPHRENIA RESEARCH (2004)
Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics
M Turner et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2004)
Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder
R Lasser et al.
JOURNAL OF AFFECTIVE DISORDERS (2004)
Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia
AM Meaney et al.
BRITISH JOURNAL OF PSYCHIATRY (2004)
Treatment of schizophrenia with long-acting injectable risperidone: A 12-month open-label trial of the first long-acting second-generation antipsychotic
WW Fleischhacker et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Antipsychotic-induced type 2 diabetes: Evidence from a large health plan database
F Gianfrancesco et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2003)
Increased suicide attempt rate among patients interrupting use of atypical antipsychotics
RMC Herings et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2003)
Long-acting injectable risperidone: Efficacy and safety of the first long-acting atypical antipsychotic
JM Kane et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Long-acting risperidone:: Prolonged-release injectable delivery of risperidone using medisorbò: Microsphere technology
M Ramstack et al.
SCHIZOPHRENIA RESEARCH (2003)
Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics
JP Lindenmayer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases
LL Judd et al.
JOURNAL OF AFFECTIVE DISORDERS (2003)
Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization
J Scott et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
The long-term natural history of the weekly symptomatic status of bipolar I disorder
LL Judd et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Nonadherence with mood stabilizers: Prevalence and predictors
J Scott et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Treatment non-adherence in affective disorders
R Lingam et al.
ACTA PSYCHIATRICA SCANDINAVICA (2002)
Current research on rapid cycling bipolar disorder and its treatment
JR Calabrese et al.
JOURNAL OF AFFECTIVE DISORDERS (2001)
Using drug claims data to assess the relationship of medication adherence with hospitalization and costs
BL Svarstad et al.
PSYCHIATRIC SERVICES (2001)
Bipolar disorder therapeutics: Maintenance treatment
GS Sachs et al.
BIOLOGICAL PSYCHIATRY (2000)
分享论文
